HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-hydroxy-3,2'-dimethyl-4-aminobiphenyl

Also Known As:

OH-DMABP

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        Aminobiphenyl Compounds
        N-hydroxy-3,2'-dimethyl-4-aminobiphenyl: 3

Related Diseases

1.	Body Weight (Weight, Body) 07/01/1992 - "Groups of F344 rats were administered biweekly intraperitoneal injections of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl (N-OH-DMAB) at a dose of 5, 10 or 20 mg/kg body weight or DMAB, the parent compound, at a dose of 25 mg/kg body weight, for a total of 10 times. " 04/01/1990 - "Groups of F344 and Wistar rats were given an intraperitoneal injection of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl (N-OH-DMAB) at a dose of 5 mg/kg body weight with a 1-week dietary pretreatment with ethinyl estradiol (EE), and this regimen was repeated 10 times at one-week intervals. "
2.	Carcinogenesis 06/01/1986 - "AcCoA-dependent activation of N-OH-DMABP was also detected with rat tissue cytosols from intestine, mammary gland and kidney, which like the liver, are targets for arylamine-induced tumorigenesis. "
3.	Carcinoma (Carcinomatosis) 04/01/1990 - "Selective induction of prostate carcinomas in F344 rats treated with intraperitoneal injections of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl."

Related Drugs and Biologics

1.	hydroxide ion
2.	Ethinyl Estradiol (Estinyl)

Related Therapies and Procedures

1.	Intraperitoneal Injections